Heidi, a Melbourne-based healthcare AI platform, announced the launch of Heidi Evidence and the acquisition of UK-based clinical AI company AutoMedica as it expands beyond documentation into real-time clinical reasoning and communications. The company also introduced Heidi Comms, an AI partner designed to help healthcare teams manage patient calls, bookings, reminders, and follow-ups.
The announcements mark Heidi’s transition from an AI scribe into what it describes as a comprehensive AI Care Partner, integrating clinical documentation with evidence-based decision support. Clinical evidence plays a central role in patient care, influencing diagnoses, treatment selection, dosing, follow-up planning, and safety considerations.
Heidi Evidence is positioned to address what the company calls a growing “knowledge gap” in healthcare. With medical knowledge doubling every 73 days, clinicians face increasing difficulty staying current with research and evolving best practices. While many have turned to general-purpose AI tools, Heidi argues that those platforms often lack transparency and local clinical context, and can undermine patient confidence when clinicians rely on tools perceived as consumer search engines.
The new evidence layer is integrated directly into the Heidi platform and can also be used as a standalone tool. It is built in partnership with organizations including HealthPathways, EMGuidance, MIMS, Vidal, NICE, and BMJ Group to reflect regional standards and formularies. Heidi says the product is permanently ad-free, with auditable data sources designed to prevent commercial influence over clinical decisions. It also provides transparent citations and verbatim excerpts to enable clinicians to verify insights.
Heidi Evidence is free for individual clinicians, with enterprise revenue subsidizing access in resource-constrained or fragmented markets. The company says this model offers a professional alternative to ad-supported consumer AI and search engines.
The acquisition of AutoMedica strengthens Heidi’s evidence-led AI framework and deepens its regulatory relationships in the UK. AutoMedica’s experience, including access to the MHRA AI Airlock regulatory sandbox, is expected to accelerate Heidi’s regulatory capabilities and expand its footprint in the UK market.
Heidi Evidence is built in part on Claude, Anthropic’s AI models, which the company says are well suited for interpreting complex clinical conversations, synthesizing medical literature, and generating grounded outputs in high-stakes healthcare environments. Heidi positions this approach as aligned with a safety-first, evidence-based philosophy.
Founded in Melbourne, Heidi is used across emergency departments, general practice, and specialist clinics. The company supports more than 2.4 million consults each week in 110 languages across 190 countries. Heidi has raised $96.6 million from investors including Point72 Private Investments, Blackbird, Headline, Phoenix Court’s growth fund Latitude, Possible Ventures, and Archangel. The company adheres to standards including NHS, HIPAA, GDPR, and Australian Privacy Principles, and holds SOC2 and ISO27001 certifications.
KEY QUOTES
“We believe that for AI to be a true care partner, the integrity of its evidence must be non-negotiable,” “As we see more general-purpose AI platforms like OpenAI move toward ad-supported models, consumers are rightly concerned about hidden influence. In a healthcare setting, that concern becomes paramount. Bringing transparent, clinical-grade insights into the room makes it easier to deliver quality care, but that information must be free from the ambiguity of commercial influence. By committing to Evidence being ad-free and independent, we ensure clinicians can stay present with their patients, knowing their decision-making is built on pure clinical rigor, not a business model.”
Dr. Thomas Kelly, Co-Founder And CEO Of Heidi
“Heidi is tackling one of the hardest problems in healthcare AI: how to scale capability without compromising trust,” “By treating evidence as core infrastructure, not content monetised through ads or influence, Heidi is building the kind of defensible, globally relevant platform healthcare systems are demanding.”
Michael Tolo, General Partner At Blackbird
